000 01047 a2200301 4500
005 20250515173336.0
264 0 _c20090612
008 200906s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc090579
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarcia, David A
245 0 0 _aWarfarin pharmacogenetics.
_h[electronic resource]
260 _bThe New England journal of medicine
_cJun 2009
300 _a2474; author reply 2475 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAlgorithms
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aContinuity of Patient Care
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aPharmacogenetics
650 0 4 _aWarfarin
_xadministration & dosage
700 1 _aHylek, Elaine
773 0 _tThe New England journal of medicine
_gvol. 360
_gno. 23
_gp. 2474; author reply 2475
856 4 0 _uhttps://doi.org/10.1056/NEJMc090579
_zAvailable from publisher's website
999 _c18918591
_d18918591